SAN JOSE, California e TAIPEI, Taiwan, 2 giugno 2026 /PRNewswire/ — Super Micro Computer, Inc. (NASDAQ: SMCI), fornitore di soluzioni IT complete per IA, cloud, storage e 5G Edge, presenta i progetti delle soluzioni modulari per data center (DCBBS) basati sulle piattaforme NVIDIA Vera Rubin NVL72 e NVIDIA HGX Rubin NVL8. I piani sono progettati per l’implementazione di data center dedicati all’IA su scala gigawatt, a partire da moduli base costituiti da una singola unità scalabile da 1.152 GPU, che può essere replicata fino a raggiungere praticamente qualsiasi dimensione. I progetti DCBBS di Supermicro comprendono la progettazione e la fornitura di una soluzione completa end-to-end, con un team dedicato di esperti che copre l’intero ciclo di vita dell’implementazione. DCBBS fornisce le risorse necessarie in termini di elaborazione, archiviazione, rete, raffreddamento a liquido avanzato, distribuzione dell’alimentazione e infrastruttura in loco, accelerando i tempi di messa in linea delle fabbriche di IA su larga scala con raffreddamento a liquido. 

“La piattaforma NVIDIA Vera Rubin NVL72 definisce un nuovo standard per le prestazioni dell’IA in ambito industriale, e i nostri progetti DCBBS offrono ai clienti un percorso collaudato e completo per realizzare impianti su qualsiasi scala, da 5 MW a 1 GW”, ha affermato Charles Liang, presidente e amministratore delegato di Supermicro. “Abbiamo realizzato alcune delle prime e più grandi fabbriche di IA raffreddate a liquido, e quell’esperienza è integrata in ogni progetto: in questo modo i nostri clienti possono passare dalla progettazione alla piena operatività più in fretta che mai.”I progetti DCBBS di Supermicro affrontano le sfide legate all’implementazione pratica delle infrastrutture di IA più avanzate al mondo. La piattaforma NVIDIA Vera Rubin migliora notevolmente la densità prestazionale delle fabbriche di IA, raddoppiando la velocità in diversi ambiti di elaborazione. L’ultima architettura di riferimento di NVIDIA definisce con precisione quali caratteristiche debba avere un’unità scalabile ideale da 1.152 GPU, mentre il progetto DCBBS di Supermicro illustra i passaggi necessari per garantire il successo dell’implementazione, forte di una comprovata esperienza nella realizzazione delle più grandi strutture al mondo dedicate all’IA con raffreddamento a liquido, dotate di oltre 100.000 GPU. 

Per ulteriori informazioni sui progetti DCBBS, visitare https://www.supermicro.com/en/solutions/dcbbs
 

Il progetto DCBBS di Supermicro affronta la realtà dell’implementazione delle fabbriche di IA 

I clienti che intendono realizzare o ristrutturare impianti industriali basati sull’IA partono da un vincolo imprescindibile: la potenza disponibile. I progetti DCBBS per NVIDIA Vera Rubin NVL72 presentano una distinta base bilanciata per un determinato envelope di potenza, compreso tra 5 MW e 1 GW, e offrono il giusto rapporto tra capacità di raffreddamento, erogazione di potenza, nodi di calcolo, nodi di gestione, nodi di archiviazione ad alte prestazioni, nodi della piattaforma di archiviazione della memoria di contesto e rete per garantire prestazioni ottimali in presenza di colli di bottiglia quali sovra-sottoscrizione di rete, limitazioni della capacità di alimentazione, throttling termico o altri ostacoli. 

I progetti coprono l’intero processo end-to-end che Supermicro ha utilizzato efficacemente per completare progetti di IA su larga scala a velocità da record: 

I progetti DCBBS di Supermicro sono in linea con l’architettura di riferimento per NVIDIA Vera Rubin NVL72 

La piattaforma NVIDIA Vera Rubin ha il potenziale per apportare miglioramenti prestazionali rivoluzionari rispetto alle generazioni precedenti, ma richiede un approccio ripetibile e affidabile per essere implementata con successo. Supermicro garantisce la conformità con la più recente architettura di riferimento NVIDIA, assicurando ai clienti che la loro implementazione sia in linea con l’ecosistema dei partner cloud NVIDIA. 

Le unità scalabili che costituiscono il cuore dei progetti DCBBS di Supermicro sono dotate di 1.152 GPU NVIDIA Rubin con 331 TB di memoria HBM4. La generazione Vera Rubin raddoppia la larghezza di banda della memoria della GPU, la larghezza di banda NVLink tra GPU e la larghezza di banda di rete per singola GPU rispetto a NVIDIA Blackwell, fornendo le basi architetturali per l’addestramento e l’inferenza di modelli di IA all’avanguardia con diversi trilioni di parametri. 

2 rack per piattaforme di archiviazione della memoria contestuale ottimizzati per gestire le esigenze relative all’inferenza con contesti estesi, alla memoria di lavoro agentica e ai carichi di lavoro di recupero dati. 

Per ulteriori informazioni visitare https://www.supermicro.com/en/accelerators/nvidia/vera-rubin
.
 

Il modello DCBBS di Supermicro garantisce la responsabilità di un unico fornitoreLa realizzazione di una tipica infrastruttura di IA comporta rapporti con più di una dozzina di fornitori diversi nei settori di elaborazione, archiviazione, reti, rack, distribuzione del raffreddamento, torri di raffreddamento, infrastruttura di alimentazione, sistemi di backup a batteria, cablaggio, ricetrasmettitori e servizi. Quando queste relazioni vengono gestite con più fornitori, ogni passaggio di consegne tra un fornitore e l’altro comporta rischi in termini di tempistiche e problemi di responsabilità, che rallentano le implementazioni e complicano il processo di risoluzione dei problemi. 

I progetti DCBBS per NVIDIA Vera Rubin NVL72 e NVIDIA HGX Rubin NVL8 sono ora disponibili per i progetti dei clienti con implementazioni previste per la seconda metà del 2026, in linea con la disponibilità generale di NVIDIA Vera Rubin. Supermicro presenterà le piattaforme NVIDIA Vera Rubin NVL72 e NVIDIA HGX Rubin NVL8 allo stand N0824 del Computex, che si terrà dal 2 al 6 giugno 2026 a Taipei, Taiwan, con ulteriori dimostrazioni in occasione dell’NVIDIA GTC Taipei. 

Informazioni su Super Micro Computer, Inc. 

Supermicro (NASDAQ: SMCI) è leader mondiale nelle soluzioni IT complete, ottimizzate per le applicazioni. Fondata e con sede a San Jose, in California, Supermicro si impegna a fornire innovazioni all’avanguardia per infrastrutture IT aziendali, cloud, AI e 5G Telco/Edge. Ci stiamo trasformando in un fornitore di soluzioni IT complete, con sistemi, software e servizi relativi a server, intelligenza artificiale, storage, IoT e switch, fornendo al contempo prodotti avanzati ad alto volume quali schede madri, alimentatori e chassis. Le soluzioni di Supermicro sono progettate e realizzate internamente (negli Stati Uniti, a Taiwan e nei Paesi Bassi), sfruttando le operazioni globali per ottenere scalabilità ed efficienza, e ottimizzati per migliorare il costo totale di proprietà e ridurre l’impatto ambientale (informatica ecosostenibile). Il pluripremiato portafoglio di Server Building Block Solutions consente ai clienti di ottimizzare il proprio carico di lavoro e le proprie applicazioni, attingendo a un’ampia gamma di sistemi costruiti con i nostri moduli flessibili e riutilizzabili, che supportano una serie completa di fattori di forma, processori, memoria, GPU, archiviazione, networking, alimentazione e soluzioni di raffreddamento (ad aria, ad aria libera o a liquido). 

Foto – https://mma.prnewswire.com/media/2991542/PR_Image_NVIDIA_Vera_Rubin_CM_r1.jpgLogo – https://mma.prnewswire.com/media/1443241/Supermicro_Logo.jpg
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

FRANKFURT, Germany, June 2, 2026 /PRNewswire/ — At the recent 2026 meetings of the International Organization for Standardization’s Technical Committee on Cranes (ISO/TC96) in Frankfurt, Germany, more than 100 representatives from 16 member countries — including China, Germany, France, the United States, the United Kingdom, Australia, Finland, and Japan — gathered to discuss the future of international crane standards. XCMG Vice President and Chief Engineer Shan Zenghai led the company’s technical expert team as part of the Chinese delegation, contributing to discussions across multiple key standards initiatives. 

Ahead of the meetings, the Chinese delegation coordinated technical proposals and standards priorities across key working groups. During the sessions, delegates contributed to discussions on crane safety, inspection, and mobile crane operations, helping advance several international standards initiatives. 

During the meetings, Shan Zenghai — serving as the convener of the working group on “Safe Use of Mobile Cranes” — reported on the progress of ISO 12480-2, Cranes — Safe Use — Part 2: Mobile Cranes, a standard led by China. His update moved the project forward to the Draft International Standard (DIS) stage. 

Representing the Chinese delegation, XCMG’s technical experts also proposed a new work item for ISO 9927-2, Cranes — Inspection — Part 2: Mobile Cranes, which drew strong interest from international experts. In addition, the team helped advance work on revisions to ISO 9927-1, Cranes — Inspection — Part 1: General, while also taking on responsibility for two additional international standard revision projects. Through these efforts, Chinese companies represented by XCMG contributed their technical expertise to next-generation crane technologies. 

The meetings also advanced work related to 14 international crane standards led or revised by China, while two new international proposals were submitted and six additional international standard projects were undertaken under Chinese leadership. These developments further strengthened China’s role in international crane standardization and reinforced the country’s position as a major global crane manufacturing hub. 

Currently ranked as the world’s third-largest construction equipment manufacturer, XCMG has led or played a core role in the development of more than 10 international standards to date. From exporting products to helping shape global standards, XCMG continues to support the advancement of Chinese manufacturing across the global industrial value chain while contributing to technological innovation and industry upgrades throughout the construction equipment sector. 

View original content:https://www.prnewswire.co.uk/news-releases/chinese-standards-go-global-xcmg-helps-advance-international-crane-industry-standards-302788295.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

L’eccellenza agroalimentare toscana sbarca nel cuore istituzionale dell’Unione Europea per celebrare un traguardo storico nazionale. In occasione dell’ottantesimo anniversario del referendum istituzionale del 2 giugno 1946, la birra artigianale della nostra regione è stata scelta per rappresentare il ‘Made in Italy’ durante i festeggiamenti ufficiali della Festa della Repubblica a Bruxelles. L’evento si svolge all’interno del palazzo di Avenue Legrand, residenza ufficiale dell’Ambasciatrice d’Italia in Belgio, Federica Favi.

La Maremma sul podio europeo

A tenere alto il vessillo della Toscana in questa prestigiosa vetrina internazionale è il Birrificio Ad-Meata Brew House, realtà produttiva situata a Santa Fiora, in provincia di Grosseto. L’azienda maremmana partecipa alla degustazione grazie al trionfo ottenuto a Birra dell’Anno 2026, il prestigioso concorso nazionale curato da Unionbirrai. Il birrificio si è infatti aggiudicato la medaglia d’oro nella categoria ‘Birra alle Castagne’ grazie alla sua creazione denominata ‘La Gatta’, un prodotto profondamente legato alle materie prime e alla cultura del proprio territorio d’origine.

La spedizione oltreconfine è il frutto di una stretta sinergia tra Unionbirrai e Cia-Agricoltori Italiani, nata con il preciso obiettivo di inserire il comparto brassicolo indipendente all’interno della narrazione della qualità agroalimentare italiana. La selezione presentata a Bruxelles offre uno spaccato di un settore che negli ultimi trent’anni ha consolidato la propria autorevolezza e riconoscibilità nel mondo. I prodotti portati in Belgio derivano da una severa selezione effettuata durante l’edizione 2026 del concorso, che ha visto sfidarsi produzioni suddivise in 46 categorie distinte, vagliate da una giuria di esperti e degustatori di livello internazionale.

Il valore del Made in Italy indipendente

A guidare la delegazione a Bruxelles è il segretario generale di Unionbirrai, Simone Monetti, il quale ha espresso profonda soddisfazione per il valore istituzionale dell’iniziativa. Queste le sue dichiarazioni integrali: “Portare la birra artigianale italiana dall’Ambasciatrice d’Italia a Bruxelles, nel giorno della Festa della Repubblica e nell’anno dell’ottantesimo anniversario del referendum del 2 giugno 1946, ha un valore particolarmente significativo – dichiara Monetti –. Significa raccontare un’Italia produttiva, creativa e indipendente, capace di esprimere qualità attraverso le proprie comunità, i propri territori e le propri imprese. La birra artigianale italiana è ormai parte pienamente riconosciuta del patrimonio agroalimentare nazionale e occasioni come questa consentono di farla conoscere in un contesto istituzionale europeo di grande prestigio. Desideriamo ringraziare Cia-Agricoltori Italiani – aggiunge il segretario generale Unionbirrai – per aver reso possibile questa presenza e per aver voluto includere le birre artigianali italiane all’interno di un racconto corale del Made in Italy. È un segnale importante, perché la birra artigianale nasce dall’incontro tra competenza brassicola, filiera agricola, cultura del territorio e capacità di innovare. Brindare alla Repubblica con queste birre significa anche rendere omaggio al lavoro di tanti piccoli produttori indipendenti che ogni giorno contribuiscono alla qualità e alla reputazione dell’Italia”.

Il contributo toscano si inserisce in un ricco mosaico di produzioni d’eccellenza provenienti da svariate regioni della penisola, che Monetti ha sintetizzato evidenziando la maturità del movimento: “Quella che arriva a Bruxelles – conclude Monetti – è una fotografia della straordinaria varietà della birra artigianale italiana: basse fermentazioni, luppolate moderne, birre alle castagne, scure, saison, produzioni a baixa gradazione e analcoliche, interpretazioni territoriali e collaborazioni. È la dimostrazione di un movimento maturo, vivo, capace di parlare al consumatore contemporaneo senza perdere il legame con le proprie radici”.

REDAZIONE

NetBet espande la sua offerta aggiungendo Endorphina al suo parco titoli
 

ROMA, Italia, June 02, 2026 (GLOBE NEWSWIRE) — NetBet rinforza la sua partnership con il noto provider di slot Endorphina, consolidando ulteriormente la propria offerta per i giocatori del mercato italiano. 

Questa rinnovata collaborazione riflette il costante impegno di NetBet nel collaborare con i migliori produttori del settore, arricchendo il catalogo del proprio casinò con titoli di alta qualità e successo internazionale come “Crown Coins”, “Lucky Streak 1000” e “Burning Coins 20”. 

Nel corso degli anni, Endorphina si è affermata come una delle aziende più autorevoli del settore, celebre per la creazione di giochi dal forte impatto visivo e dalle meccaniche innovative, che hanno riscosso grande popolarità nei principali mercati regolamentati a livello globale. 

Mario Crupi, Regional Manager per l’Italia di Endorphina, ha dichiarato: “Questa partnership è per noi fonte di grande orgoglio. Collaborare con un operatore di primo livello come NetBet rafforza la credibilità e la professionalità del nostro brand. Questo accordo rappresenta la conferma concreta del valore del lavoro che svolgiamo quotidianamente”. 

Giuseppe Festoni, Casino Manager di NetBet Italia, ha aggiunto: “Siamo entusiasti di migliorare la sinergia con Endorphina sulla nostra piattaforma. Siamo certi che questa cooperazione continuerà a portare risultati eccellenti, offrendo la migliore esperienza di gioco possibile ai nostri utenti”. 

Con questo nuovo accordo, Endorphina amplia la propria presenza sui mercati internazionali, consolidando il proprio ruolo di partner strategico per i principali operatori del settore iGaming in Italia. 

Per ulteriori informazioni, contattare pr@netbet.com
 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/globenewswire

Leading online casino expands gaming library with Endorphina titles
 

ROMA, Italy, June 02, 2026 (GLOBE NEWSWIRE) — Leading online gaming operator NetBet has reinforced its collaboration with renowned slot provider Endorphina, in an ongoing effort to strengthen their portfolio with the best content on the market and provide the highest quality to players nationwide. 

The renewed collaboration reflects NetBet’s ongoing strategy to work with leading content providers and continuously enhance its casino offering with high-quality, engaging, and internationally recognised games such as “Crown Coins”, “Lucky Streak 1000” and “Burning Coins 20”. 

Over the years, Endorphina has established itself as one of the industry’s most respected providers, known for delivering visually engaging slot experiences and innovative mechanics that have gained popularity with players across regulated markets worldwide. 

Mario Crupi, Regional Manager Italy at Endorphina, said: “This collaboration is a source of great pride for us. Having a top-tier operator like NetBet in our portfolio further strengthens the credibility and professionalism of our brand. This renewed collaboration is concrete confirmation of the value of the work we are building every day.” 

Giuseppe Festoni, Casino Manager at NetBet Italy, added: “We are delighted to further strengthen our collaboration with Endorphina on the NetBet Italy platform. We look forward to continuing a strong and successful collaboration together to further enhance our customer’s experience.” 

With this latest agreement, Endorphina continues to expand its footprint across international regulated markets, further reinforcing its position as a strategic partner for major operators within the Italian iGaming industry. 

For more information, contact pr@netbet.com
 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/globenewswire

Limited to 200 pieces worldwide, the collection combines a genuine Muonionalusta meteorite dial with SEA-GULL’s upgraded in-house ST1961-2 split-seconds caliber. 

NEW YORK and TIANJIN, China, June 2, 2026 /PRNewswire/ — SEA-GULL has officially launched its Meteorite Rattrapante Chronograph Limited Edition, available exclusively on Kickstarter. This release marks the first time the historic manufacture has offered a meteorite dial paired with a mechanical split-seconds complication directly to global collectors via a crowdfunding platform. 

The Kickstarter campaign offers early-bird pricing starting at HK$35,649 (US$4,549) per watch, or HK$33,669 (US$4,250) per watch in the two-piece tier. MSRP is US$5,200. 

Genuine Muonionalusta MeteoriteEach watch dial is precision-cut from the Muonionalusta meteorite, which struck Earth millions of years ago. Having cooled over eons in the vacuum of space, the material exhibits distinct Widmanstätten patterns, natural crystalline structures unique to every individual timepiece. Consequently, no two watches in this 200-piece run feature the same face. 

In-House Calibre ST1961-2: A Manual-Winding Rattrapante with Visible CharacterThe rattrapante (split-seconds) chronograph, is considered one of the most mechanically complex chronograph complications, traditionally reserved for timepieces priced above five figures. SEA-GULL developed the calibre ST1961-2 based on the ST19 chronograph architecture and caliber ST1961, the first split-seconds chronograph movement from SEA-GULL. 

The movement features a column-wheel construction and an independent pusher at 10 o’clock, allowing the wearer to split, stop, and reset two superimposed chronograph seconds hands. This enables measurement of split times or two concurrent events. The movement is visible through a sapphire crystal display caseback. 

Compared with the earlier ST1961 movement, the ST1961-2 features updated finishing, flamed-blued steel screws, and refinements to both visual presentation and mechanical performance. 

Grade-5 Titanium Case with 1963 Aviation DNAThe 42.5mm case is machined from grade-5 titanium, selected for its high strength-to-weight ratio, corrosion resistance, and hypoallergenic properties. The design draws from Seagull 1963 chronograph, a nod to the brand’s military and pilot watch lineage. 

Availability and Special Collector PackageThe Meteorite Rattrapante Chronograph is limited to 200 pieces worldwide. Alongside the single-piece offerings, SEA-GULL is also offering a collector package featuring both the Meteorite Rattrapante Chronograph and the newly introduced Seagull 1963 Meteorite Dial Edition. Together, the two models trace the evolution of the brand’s aviation chronographs. The collection spans from the iconic 1963 which inspired generations of SEA-GULL pilot’s watches, to the brand’s most advanced split-seconds chronograph developed to date. 

To learn more about the campaign, visit SEA-GULL on Kickstarter. 

Deliveries are expected to begin in July 2026, with backers notified in order of pledge. 

About SEA-GULL Watch GroupFounded in 1955, Tianjin SEA-GULL Watch Group is among China’s longest-established mechanical watch manufacturers. Best known for the iconic Seagull 1963, China’s first aviation chronograph, the brand has mastered complex horological technologies including tourbillon, perpetual calendar, minute repeater, and rattrapante mechanisms. In 2025, SEA-GULL launched its global official website at en.seagullwatch.com. 

Photo – https://mma.prnewswire.com/media/2993072/SEA_GULL_Launches_World_s_First_Meteorite_Rattrapante_Chronograph_on_Kickstarter_1.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/a-kickstarter-first-sea-gull-debuts-meteorite-rattrapante-chronograph-limited-edition-302788222.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

New unit to deliver end-to-end Gemini-powered solutions spanning platform orchestration, agentic AI, and enterprise transformation 

LONDON, June 2, 2026 /PRNewswire/ — JK Tech, a leading Gen AI-focused data and AI services company, has announced the launch of its dedicated Gemini Enterprise Unit, marking a significant milestone in its commitment to bring cutting-edge AI capabilities to enterprise clients. The new unit is purpose-built to help organisations unlock the full potential of Google Gemini AI through structured, scalable, and business-ready frameworks, further strengthening JK Tech’s position as a one-stop destination for all Google Cloud-related services. 

From cloud data migration and agentic AI to Workspace licensing, enterprise application development, and multi-agent orchestration, JK Tech offers a comprehensive, end-to-end Google Cloud portfolio that eliminates the need for enterprises to look beyond a single trusted partner. 

Built on JK Tech’s proven AI and data capabilities, the Gemini Enterprise Unit will enable enterprises to rapidly move from AI experimentation to scalable production deployments. The practice will combine Google’s advanced AI technologies with JK Tech’s proprietary solutions, including JIVA, an Agentic AI Orchestrator, and Orbiee, a conversational commerce platform, to deliver industry-specific outcomes across Retail, Consumer Packaged Goods (CPG), Insurance, and other data-intensive sectors. These platforms enable seamless coordination of AI agents, workflows, and enterprise data, helping businesses operationalise Gemini at scale with speed and confidence. 

Further strengthening the partnership with Google Cloud, JK Tech will deepen its Google Workspace practice with focused offerings across cloud data migration, agentic AI, and enterprise Workspace adoption, helping organisations modernise their collaboration infrastructure alongside their broader AI transformation journey. 

“The launch of our Gemini Enterprise Unit is a defining moment for JK Tech. It reflects our strategic vision to provide clients with a comprehensive Google Cloud-led transformation journey from data modernisation and cloud migration to Gemini-powered AI, agentic workflows, and business innovation. We are not just implementing AI; we are architecting intelligent enterprises. With JIVA and Orbiee at the core, we are giving our clients a future-proof foundation to scale Gemini across every layer of their business,” said Tanuj Singh, Sr. VP, Head- Marketing & UK/Europe Sales at JK Tech. 

Adding to this, Vedang Singhania, Head of Sales – New Business at JK Tech, said, “Gemini represents a generational shift in how enterprises will decide, work, and grow. At JK Tech, we have built the capabilities, platforms, and partnerships to be the most reliable Google Cloud partner an enterprise can have. We look forward to deepening these conversations on the global stage, including at the upcoming Google Cloud Summit Nordics on June 3rd, where we hope to explore exciting new opportunities ahead.” 

JK Tech’s Gemini Enterprise Unit is available to clients across industries seeking to accelerate their AI adoption journey with trusted implementation expertise and enterprise-grade infrastructure. 

About JK Tech 

JK Tech is a leading AI and data solutions company helping enterprises accelerate transformation through Google Cloud, Gemini, and Agentic AI. As a strategic Google Cloud partner, JK Tech delivers cloud modernisation, data platforms, analytics, AI engineering, intelligent automation, and enterprise AI solutions. Its proprietary platforms- JIVA, the Agentic AI Orchestrator, Ontologos, the semantic intelligence platform, and Orbiee, the conversational commerce platform enable organisations to unlock trusted insights, automate decisions, and scale AI adoption. 

To learn more, visit www.jktech.com. Find JK Tech on X, LinkedIn
 

Logo: https://mma.prnewswire.com/media/2088130/5996584/JK_Tech_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/jk-tech-launches-dedicated-gemini-enterprise-unit-to-accelerate-ai-adoption-across-enterprises-302787117.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

Editorial Link Intelligence leverages Infosys Aster and automates editorial workflows to accelerate content delivery and drives deeper reader engagement 

DÜSSELDORF, Germany and BENGALURU, India, June 2, 2026 /PRNewswire/ — Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, and the Handelsblatt Media Group, Germany’s leading media group for business and finance, today announced the launch of Editorial Link Intelligence (ELI). Leveraging Infosys Aster, an AI-amplified marketing suite, this editorial recommendation engine, developed exclusively for Handelsblatt and WirtschaftsWoche, is designed to elevate digital journalism by delivering enhanced storytelling and driving deeper reader engagement. The launch of ELI marks a key milestone in Infosys’ three-year collaboration with Handelsblatt as its official AI & Digital Innovation Partner. 

ELI is designed to help modernize Handelsblatt and WirtschaftsWoche editorial operations and deliver more context-rich content experiences to its diverse reader base. Developed by Wongdoody, Infosys’ human experience agency, the solution analyses article content and metadata to intelligently recommend internal links that enhance narrative depth and reader navigation. Seamlessly integrated into Handelsblatt and WirtschaftsWoche content infrastructure, ELI enables editors to enrich stories without interrupting their workflow – freeing time for qualitative reporting, research, and analysis. 

The impact of ELI spans the entire publishing ecosystem. For editorial teams, it streamlines link curation and improves operational efficiency. For readers, it creates more immersive and intuitive journey through complex topics. For publishers, it drives measurable outcomes – boosting engagement, increasing time spent on the site, and reinforcing the value of trusted journalism in a competitive digital landscape. 

Christian Herp, Chief Product Officer, Handelsblatt Media Group, said, “Editorial Link Intelligence we developed together with Infosys creates direct value for our editorial teams through the targeted use of AI. By integrating the tool into our content management system, it supports journalists in identifying and linking relevant content. In this way, we are sustainably enhancing the user experience and increasing customer satisfaction.” 

Charlotte Morré, Member of the Editorial Board, Handelsblatt, said, “Editorial Link Intelligence helps us provide readers with more context and relevant related content on a given topic, giving them better guidance and orientation. What is equally important to us, however, is that the final review and editorial control of this content remain firmly with our newsroom colleagues. In this way, the solution strengthens the quality of the digital user experience while giving our teams more time for research, analysis, and exclusive stories.” 

Ashiss Kumar Dash, EVP and Services, Utilities, Resources, Energy & Enterprise Sustainability said, “By combining Infosys’ expertise with Handelsblatt’s editorial excellence, we are creating a blueprint for the future of intelligent storytelling. Editorial Link Intelligence leverages Infosys Aster’s strengths in creating impactful digital experiences and demonstrates how AI can amplify journalistic craft, not by replacing human judgement, but by enriching every article with deeper context, smarter navigation, and more relevant insights. This technology ultimately helps readers engage with complex topics more intuitively and meaningfully, while giving Handelsblatt and WirtschaftsWoche a clear competitive edge in delivering the most contextual, high-quality business journalism in the market.” 

About the Handelsblatt Media Group 

Handelsblatt Media Group is Germany’s leading media house for business and financial information. With its two brands, Handelsblatt and WirtschaftsWoche, it reaches more than 3.7 million readers each week and stands for in-depth, independent quality journalism, exclusive networks and high-profile events. Headquartered in Düsseldorf, the media group was founded in 1946 and is part of Dieter von Holtzbrinck Medien. 

Handelsblatt Media Group includes the leading marketer of quality media, iq digital media marketing gmbh, the specialist in corporate content, concept, and marketing, Solutions by Handelsblatt Media Group GmbH and other holdings. 

About Infosys 

Infosys is a global leader in AI first business consulting and technology services. Over 325,000 of our people work to amplify human potential and create the next opportunity for people, businesses, and communities. As navigators of enterprise transformation, we enable businesses in 63 countries to unlock AI value at scale. With over four decades of experience in managing the systems and workings of global enterprises, we accelerate business transformation through our AI-first value framework, deep domain expertise, and our unique ability to orchestrate innovations from our AI-native partner ecosystem. Infosys is counted among the world’s Top 100 brands committed to being a well-governed, environmentally sustainable partner for our clients where deep talent expertise, in an inclusive workplace, help them navigate their next. 

Visit www.infosys.com to see how Infosys (NSE, BSE, NYSE: INFY) can help your enterprise navigate your next. 

Safe Harbor 

Certain statements in this release concerning our future growth prospects, or our future financial or operating performance, are forward-looking statements intended to qualify for the ‘safe harbor’ under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results or outcomes to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the execution of our business strategy, increased competition for talent, our ability to attract and retain personnel, increase in wages, investments to reskill our employees, our ability to effectively implement a hybrid work model, economic uncertainties and geo-political situations, technological disruptions and innovations such as artificial intelligence (“AI”), generative AI, the complex and evolving regulatory landscape including immigration regulation changes, our ESG vision, our capital allocation policy and expectations concerning our market position, future operations, margins, profitability, liquidity, capital resources, our corporate actions including acquisitions, and cybersecurity matters. Important factors that may cause actual results or outcomes to differ from those implied by the forward-looking statements are discussed in more detail in our US Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2025. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the Company’s filings with the Securities and Exchange Commission and our reports to shareholders. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company unless it is required by law. 

Logo: https://mma.prnewswire.com/media/633365/5460444/Infosys_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/infosys-and-handelsblatt-media-group-unveil-ai-powered-editorial-engine-to-enhance-storytelling-and-enrich-reader-experience-302788200.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

WATERLOO, ON, 2 giugno 2026 /PRNewswire/ — OpenText™ (NASDAQ/TSX: OTEX), leader mondiale nella gestione dei dati per l’IA aziendale, ha aderito oggi all’HAIP (Hiroshima AI Process) Reporting Framework dell’OCSE, il meccanismo internazionale attraverso il quale le organizzazioni dimostrano la propria conformità al codice di condotta volontario del G7 per lo sviluppo e l’implementazione sicuri dell’IA avanzata. 

“La fiducia nell’intelligenza artificiale parte dai dati su cui si basa il modello e dal modo in cui questi vengono gestiti, protetti e contestualizzati”, ha affermato Ayman Antoun, amministratore delegato di OpenText. “OpenText lavora a questa base da 35 anni. “La nostra partecipazione all’HAIP rappresenta una naturale estensione di tale impegno e garantisce che il quadro globale emergente rifletta le realtà dell’implementazione dell’IA agentica a livello aziendale.” 

Questa iniziativa pone OpenText, responsabile della gestione dei dati relativi a persone, macchine e transazioni per oltre 120.000 aziende ed enti governativi in 180 Paesi, in prima linea nel garantire che l’intelligenza artificiale autonoma sia affidabile e generi un valore tangibile sia per il settore pubblico che per quello privato. Attraverso la rete aziendale di OpenText transitano ogni anno oltre 15.000 miliardi di dollari canadesi (CAD) di scambi commerciali B2B; l’azienda gestisce inoltre i contenuti non strutturati e i dati operativi generati automaticamente su cui le imprese soggette a regolamentazione basano la propria attività quotidiana, il che le conferisce una base di dati particolarmente ampia da apportare al dibattito politico globale. 

Le basi dei dati per un’intelligenza artificiale affidabileOpenText gestisce i tre ambiti di dati fondamentali per l’IA aziendale: i dati umani, ovvero i contenuti non strutturati, i documenti e gli archivi che racchiudono il sapere organizzativo; i dati delle macchine, ovvero le informazioni operative e generate dai sistemi provenienti dalla gestione dei servizi IT, dalla sicurezza informatica e dalle piattaforme della catena di fornitura; e i dati transazionali, ovvero i flussi commerciali B2B e gli eventi della catena di fornitura che coinvolgono oltre un milione di partner commerciali in tutto il mondo. Le soluzioni di intelligenza artificiale OpenText Aviator sono integrate in questo ecosistema regolamentato, garantendo sicurezza di livello aziendale, controlli di conformità e tracciabilità dei dati in ogni interazione basata sull’IA, a diretto sostegno dei principi di trasparenza e responsabilità che HAIP si propone di promuovere. 

“Siamo i primi a utilizzare i nostri prodotti e la nostra intelligenza artificiale, quindi sappiamo per esperienza diretta che un’IA autonoma affidabile parte dalla governance dei dati. Prima di qualsiasi implementazione dell’intelligenza artificiale, la prima domanda che ci poniamo è: in che modo i dati vengono gestiti, protetti e controllati? È proprio questa la disciplina che HAIP codifica, ed è per questo che aderire a questo quadro normativo è stata la scelta giusta per OpenText e per i clienti che serviamo in tutto il mondo”, ha affermato Shannon Bell, vicepresidente esecutiva, direttrice digitale e responsabile dei sistemi informativi di OpenText. 

Rafforzare la leadership del Canada nel campo dell’IA responsabileOpenText è stata tra i primi firmatari del Codice di condotta volontario del Canada sullo sviluppo e la gestione responsabili dei sistemi avanzati di IA generativa. La sua partecipazione all’HAIP collega tale impegno nazionale alle norme del G7, rafforzando la posizione del Canada come leader mondiale nel campo dell’IA e il ruolo di OpenText nel promuovere una governance responsabile dell’IA a livello internazionale. 

Informazioni su OpenTextOpenText™ è leader mondiale nella gestione dei dati per l’intelligenza artificiale a livello aziendale, consentendo alle organizzazioni di proteggere, gestire e sfruttare i propri dati in tutta sicurezza. Scopri di più su www.opentext.com. 

Avviso relativo alle dichiarazioni previsionaliAlcune dichiarazioni contenute nel presente comunicato stampa possono contenere termini considerati dichiarazioni o informazioni previsionali ai sensi delle leggi vigenti in materia di titoli. Tali dichiarazioni si basano su aspettative, valutazioni, previsioni e proiezioni attuali di OpenText relative al contesto operativo, alle economie e ai mercati in cui opera la società. Tali dichiarazioni sono soggette a ipotesi, rischi e incertezze significativi difficili da prevedere, e i risultati effettivi potrebbero differire in modo sostanziale. Le ipotesi formulate da OpenText, sebbene ritenute ragionevoli dalla società alla data del presente comunicato stampa, potrebbero rivelarsi inesatte e, di conseguenza, i risultati effettivi potrebbero differire in modo sostanziale dalle aspettative qui esposte. Per ulteriori informazioni sui rischi e altri fattori che potrebbero verificarsi, si rimanda alla Relazione annuale di OpenText sul modulo 10-K, alle Relazioni trimestrali sul modulo 10-Q e ad altri documenti depositati presso la SEC e altre autorità di regolamentazione dei mercati finanziari. Si raccomanda ai lettori di non fare eccessivo affidamento su tali dichiarazioni previsionali, che sono valide solo alla data in cui sono state formulate. Salvo quanto diversamente previsto dalle leggi vigenti in materia di titoli, OpenText declina qualsiasi intenzione o obbligo di aggiornare o rivedere eventuali dichiarazioni previsionali, sia a seguito di nuove informazioni, eventi futuri o altro. Inoltre, i lettori devono tenere presente che potremmo comunicare informazioni tramite il nostro sito web, comunicati stampa, documenti depositati ai sensi delle leggi sui titoli, conferenze telefoniche pubbliche, webcast e i canali social indicati nella sezione Investitori del nostro sito web (https://investors.opentext.com). Tali canali social possono includere il blog della Società o dei nostri dirigenti, l’account X, precedentemente noto come Twitter, o l’account LinkedIn. Le informazioni pubblicate attraverso tali canali possono essere rilevanti. Di conseguenza, i lettori dovrebbero monitorare tali canali oltre alle altre forme di comunicazione da noi utilizzate. 

Copyright © 2026 OpenText. Tutti i diritti riservati. Marchi di proprietà di OpenText. Il nostro prodotto (o i nostri prodotti) potrebbe essere coperto da uno o più brevetti. Per ulteriori informazioni, visitare il sito web https://www.opentext.com/patents. 

OTEX 

View original content to download multimedia:https://www.prnewswire.com/it/comunicati-stampa/opentext-e-tra-le-prime-aziende-canadesi-ad-aderire-al-quadro-globale-dellocse-per-la-segnalazione-di-casi-di-ia-sicura-302788148.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

GENEVA, June 2, 2026 /PRNewswire/ — National Bank of Greece (NBG) has joined Komgo’s global trade finance network, marking a strategic milestone in the bank’s international expansion. The partnership connects NBG to a leading multi-bank digital platform trusted by corporates and financial institutions worldwide, enabling the bank to extend its trade finance capabilities beyond Greece and deepen its engagement with international clients. 

Benefits for NBG from this collaboration 

As part of its strategic vision to expand its international activities, National Bank of Greece has partnered with Komgo, a leading global digital network for trade and working-capital finance. The collaboration connects NBG to an international ecosystem of corporates and financial institutions, enabling international access for Greek corporates, while creating new origination channels across key trade corridors and client segments beyond domestic market. By leveraging Komgo’s global network and advanced technology, National Bank of Greece is now positioned to originate new opportunities, strengthen its footprint in international markets and create value for its corporate clients, contributing to a more integrated and digital trade ecosystem across the region. 

Management perspectives 

“Partnering with Komgo is fully aligned with our international ambition. It gives NBG immediate connectivity to a global network of trade participants, stronger origination in cross-border flows, and deeper engagement with international clients. As we grow our international franchise, this collaboration positions NBG as a gateway to global trade and a trusted partner for both Greek and international clients operating across borders,” said Harry C. Vovos, Assistant General Manager, Corporate and Investment Banking at NBG. 

“We are delighted to welcome National Bank of Greece to the Komgo network. NBG is a cornerstone of the Greek financial ecosystem, and their decision to join is a strong signal of the accelerating digitalisation of trade finance in the region,” said Baptiste Audren, Chief Revenue Officer at Komgo. 

About National Bank of Greece 

National Bank of Greece is one of the country’s leading financial institutions, with over 185 years of history supporting the development of the Greek economy. The Bank provides a wide range of financial services across retail, corporate and investment banking, while continuously investing in digital innovation to enhance the experience of its customers. With a strong domestic presence and growing international footprint, NBG supports businesses in achieving their growth and international expansion ambitions. 

The full announcement is available on the Komgo newsroom. 

Press Contactsanne-sophie.pinson@komgo.io christille.danset@komgo.io  

Photo – https://mma.prnewswire.com/media/2992397/Komgo.jpgLogo – https://mma.prnewswire.com/media/2828670/Komgo_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/national-bank-of-greece-joins-komgo-to-expand-international-trade-finance-capabilities-302787427.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

MIAMI, June 2, 2026 /PRNewswire/ — NatGold Digital Ltd. (“NatGold” or the “Company”), a pioneering digital gold mining company with a patent-pending process for sustainably unlocking the intrinsic value of in-ground gold resources through blockchain-based tokenization, today announced that NATG is ready for European market availability and will be accessible to eligible market participants across all 30 European Economic Area member states following acceptance of the filing of the NATG MiCA White Paper by the applicable European authority. 

“NATG was designed from the beginning as a globally relevant digital asset, and the international response to our pre-market reservation program reinforced that the NatGold model speaks to audiences well beyond any single country or market,” said Andrés Fernández, CEO of NatGold Digital Ltd. “Readiness for European market availability represents an important next step in furthering global accessibility for the token and building broader, responsible market access across leading digital asset jurisdictions. We expect to announce NATG’s European market date imminently.” 

MiCA, the Markets in Crypto-Assets Regulation, is the European Union’s harmonized regulatory framework for crypto-assets. Under MiCA, admission to trading requires a crypto-asset white paper to be prepared, notified to the applicable authority, and published in accordance with the regulation. For NatGold, acceptance of the NATG MiCA White Paper represents an important step in aligning NATG with Europe’s regulated digital asset market framework. 

With NATG set to become accessible to eligible market participants across all 30 European Economic Area member states, the planned European availability marks a major step in NatGold’s expansion beyond its previously announced planned U.S. exchange-based market introduction and into one of the world’s most important digital asset markets, furthering global accessibility for the NATG token. 

The expansion builds on the international interest demonstrated during NatGold’s pre-market reservation program, which closed with 133,518 NATG reserved by 17,466 individuals across 162 countries, representing more than US$469 million in gross BIV-referenced reservation interest. This global participation provided an early indication of market interest in NatGold’s digital mining model and its potential appeal as a digitally native, fiat-alternative store-of-value asset. 

The date of NATG’s European market availability will be announced separately. In accordance with applicable MiCA publication requirements, the NATG MiCA White Paper has been posted on NatGold’s website, where it is publicly available for review. 

Important MiCA Notice 

The NATG MiCA White Paper has been filed in accordance with applicable requirements under Regulation (EU) 2023/1114. This document was notified to the Central Bank of Ireland on April 3, 2026, and published in accordance with Article 9 of MiCA on May 7, 2026. Acceptance of the filing does not constitute approval or endorsement of NATG by any competent authority, nor should it be interpreted as a recommendation or assessment of the merits of NATG. 

About NatGold Digital Ltd.NatGold Digital Ltd. is the global leader in digital gold mining and the architect and operator of a patent-pending, non-extractive platform designed to unlock the intrinsic value of technically verified in-ground gold resources that remain securely stored in Mother Nature’s Vault. NatGold Tokens are structured to represent standardized unit interests in NatGold Certified Resources, disclosed under internationally recognized geological Technical Reports — without physical extraction, processing, or movement of gold. The result is a superior fiat money alternative designed to help lead a global monetary reformation. 

For additional background, please visit NatGold.com or our official YouTube channel for videos and information about our digital mining ecosystem: youtube.com/@NatGold_Digital. 

Contact:Media@NatGold.com
 

The information in the above release has been prepared by NatGold Digital Ltd. (“NatGold”) using its best efforts to realistically and factually present the information contained herein. However, subjective opinion, reliance on factors outside NatGold’s control, and external information sources unavoidably mean that NatGold cannot warrant the information to be exhaustive, complete, or sufficient. The information provided herein is intended solely for general informational purposes and does not constitute an offer or solicitation for the purchase or sale of any shares or securities of NatGold or for the purchase or sale of any NatGold Tokens, nor is any information contained herein intended to be construed as making a recommendation, endorsement, or solicitation to engage in any investment strategy. NatGold Tokens are not intended to be “securities” in any jurisdiction, and NatGold makes no claim or representation related to the value of NatGold or NatGold Tokens. There are substantial risks associated with investing in development-stage digital assets and technology companies. Any such investment is speculative and involves a high degree of risk, including but not limited to loss of capital. An investment in the NatGold Tokens, or any other digital asset, may not be appropriate for everyone, and you should carefully consider the appropriate risks, your financial situation, risk tolerance, and investment goals before making any investment decisions. As a digital asset, NatGold Tokens are also subject to inherent risks related to blockchain technology, including but not limited to, regulatory uncertainty, market adoption, manipulation, volatility, and cyber security risks. Prospective purchasers should conduct their own due diligence and should consult with their respective financial, legal, tax, and/or other professional advisers. 

Video – https://www.youtube.com/watch?v=AWXjw9DUJrMLogo – https://mma.prnewswire.com/media/2823081/NatGold_Digital__Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/natgold-digital-announces-natg-ready-to-enter-european-market-302787996.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

FIRENZE – Adottato dalla Regione il nuovo piano faunistico venatorio, lo strumento di programmazione che definisce le linee guida per la gestione e la tutela della fauna selvatica e per la pianificazione dell’attività venatoria sul territorio regionale. Questa mattina (2 giugno) i contenuti sono stati illustrati in Palazzo Strozzi Sacrati dal presidente Eugenio Giani insieme al sottosegretario alla presidenza Bernard Dika.

Secondo il presidente Eugenio Giani “il nuovo piano faunistico venatorio rappresenta un esempio concreto di equilibrio tra tutela dell’ambiente, gestione responsabile della fauna selvatica e regolamentazione dell’attività venatoria. La Regione Toscana ha costruito uno strumento che integra conoscenze scientifiche, esigenze del territorio e contributi a seguito di un ampio percorso partecipativo. La suddivisione in comprensori omogenei, l’individuazione puntuale degli istituti faunistici e la definizione delle aree vocate e non vocate garantiscono una gestione attenta e proporzionata, capace di coniugare conservazione della biodiversità e sostenibilità delle attività umane”.

“Il piano è frutto di un lavoro rigoroso e condiviso finalizzato ad armonizzare la salvaguardia degli ecosistemi e la regolamentazione sostenibile del prelievo venatorio – ha detto il sottosegretario Bernard Dika – Ambiente e attività antropica sono gli aspetti che rendono il nostro paesaggio unico al mondo e da sempre coesistono in equilibrio sul nostro territorio. Come Regione Toscana vogliamo confermare una visione responsabile ma anche moderna, attraverso una pianificazione precisa che parte dalle specificità territoriali”.

Il recente passaggio in giunta dà avvio alla seconda parte del percorso, dopo l’adozione avvenuta in prima battuta nel corso del 2025 in giunta e in consiglio regionale. In seguito aveva avuto luogo la fase partecipativa, un programma di incontri territoriali per illustrare i contenuti del Piano a tutti i cittadini, alle associazioni e agli enti interessati, che avevano potuto fornire le proprie osservazioni al testo adottato. La pianificazione faunistico venatoria viene attuata dalla Regione Toscana considerando le caratteristiche ambientali e socioeconomiche del territorio, con l’obiettivo di garantire la tutela e conservazione della fauna selvatica, il mantenimento degli equilibri ecologici e una regolamentazione sostenibile del prelievo venatorio. Il Piano organizza il territorio in comprensori omogenei e definisce la localizzazione e l’estensione degli istituti faunistici, degli appostamenti fissi, delle aree vocate e non vocate per gli ungulati, oltre a tutte le ripartizioni necessarie alla gestione dell’attività venatoria.

All’interno dei comprensori vengono individuate, tra le altre, zone di protezione e oasi lungo le rotte migratorie, di ripopolamento e cattura e zone di rispetto venatorio, centri pubblici e privati di riproduzione della fauna, aziende faunistico venatorie e agrituristico venatorie, aree di addestramento cani, parchi nazionali e aree protette.

Viene valorizzato il ruolo del volontariato territoriale e vengono potenziati gli investimenti nei servizi informatici e nella formazione, in particolare per la sicurezza.

Un ruolo fondamentale è stato inoltre svolto dal Nurv (Nucleo unificato regionale di valutazione e verifica degli investimenti pubblici) che ha fornito un parere obbligatorio sul piano, sancendo in questo modo la conformità alla normativa ambientale, nonché l’aderenza alle politiche regionali su scelte tecniche e gestionali.

REDAZIONE

CorrectSequence Therapeutics Reports Positive 15-Month Follow-Up Data for CS-206 

SHANGHAI, June 2, 2026 /PRNewswire/ — CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base Editing (tBE) technology for severe diseases, announced that the first sickle cell disease (SCD) patient being treated in China with its high-precision base-editing therapy CS-206 has remained free of vaso-occlusive crises (VOCs) for more than 15 months following engraftment. Starting from 60 Days after the last red-cell transfusion, the patient has remained free from VOCs and anemia for 13 consecutive months, achieving the primary efficacy endpoint. The follow-up data demonstrated favorable safety and efficacy of CS-206. 

The patient, a 21-year-old woman from Nigeria, had experienced recurrent severe VOCs prior to treatment with CS-206. After receiving CS-206 treatment in February 2025, the patient achieved rapid and efficient hematopoietic reconstitution, with neutrophil engraftment observed on Day 13 and platelet counts exceeding 50×10^9/L on Day 21 post-treatment. Within one month after treatment, fetal hemoglobin (HbF) levels increased significantly and continuously, while sickle hemoglobin (HbS) levels declined substantially and persistently. Beginning at Month 3 after treatment, the HbF-to-HbS ratio stabilized at approximately 6:4 and has remained stable thereafter. No product-related adverse events have been observed to date. 

CS-206 is a proprietary base-editing therapy independently developed by Correctseq for the treatment of SCD. The therapy utilizes the highly precise transformer Base Editor (tBE), an original gene-editing technology developed by Correctseq’s scientific co-founders (Wang et al., Nature Cell Biology, 2021), to precisely edit the HBG1/2 promoter region in autologous hematopoietic stem cells collected from patients. The editing mimics naturally occurring beneficial mutations found in healthy individuals, thereby reactivating γ-globin expression and rapidly increasing fetal hemoglobin levels. 

This therapy effectively suppresses red blood cell sickling and significantly reduces vaso-occlusive crises and hemolysis. Compared with CRISPR-based gene-editing therapies for SCD, CS-206 offers the technological advantage of precise single-base correction without introducing DNA double-strand breaks, thereby avoiding risks such as large genomic deletions, chromosomal abnormalities, and off-target mutations. It is a safer and more efficient therapeutic approach. In addition, the therapy enables rapid hematopoietic recovery and substantial elevation of fetal hemoglobin levels, reducing the proportion of sickle hemoglobin and more effectively and durably preventing red blood cell sickling. 

SCD is a hereditary hemoglobin disorder caused by mutations in the β-globin gene. Patients may experience chronic anemia, recurrent pain crises, infections, and progressive organ damage, with severe cases becoming life-threatening. Approximately 3.5% of global population carries the sickle cell mutation gene, and around 300,000 babies are born with the disease each year, with particularly high prevalence in Africa, the Mediterranean, the Middle East, and South Asia. SCD and β-thalassemia are both classified as hemoglobinopathies, among the world’s most common monogenic inherited diseases. Approximately 7% of global population carries abnormal hemoglobin genes, with an estimated 400,000 affected births annually worldwide. 

Based on the same tBE technology platform and therapeutic pathway, CS-101 developed by Correctseq for β-thalassemia has successfully cured more than ten β-thalassemia patients from China (Lai et al., Nature, 2026), Laos, Malaysia, Pakistan in clinical trials. As of the end of May 2026, all patients treated with CS-101 have remained transfusion-independent for more than 15 months, with the longest duration exceeding 30 months. 

Global recruitment for the investigator-initiated trial (IIT) of CS-206 for SCD is currently ongoing. Correctseq is accelerating the clinical development and commercialization of both CS-101 and CS-206, with the goal of providing hemoglobinopathy patients worldwide with safer, more effective, and more affordable treatment options. 

About CorrectSequence TherapeuticsCorrectSequence Therapeutics (Correctseq), is a clinical-stage biotech company employing its proprietary transformer Base Editor (tBE) to pioneer next-generation gene editing therapies. The company has developed multiple state-of-the-art base-editing systems that offer exceptional precision, minimize off-target effects, and enhance ex vivo and in vivo editing efficiency. Its robust pipeline spans genetic disorders, metabolic diseases, and cardiovascular conditions, with several programs already advancing toward clinical development. 

For more information, visit www.correctsequence.com. 

Acknowledgments: The First Affiliated Hospital of Guangxi Medical University, ShanghaiTech University, Shanghai Clinical Research and Trial Center. 

Media Contact: 

Business Cooperation: BD@correctsequence.comClinical Trial Recruitment: CT@correctsequence.com    

View original content:https://www.prnewswire.co.uk/news-releases/high-precision-base-editing-therapy-demonstrates-durable-voc-free-efficacy-and-favorable-safety-in-sickle-cell-disease-302787954.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

TAIPEI, June 2, 2026 /PRNewswire/ — Solid State Storage Technology Corporation (SSSTC), a subsidiary of Kioxia Corporation and a leading global SSD provider, is showcasing its enterprise SSDs designed for immersion cooling and engineered for AI-driven data centers, along with a comprehensive portfolio of industrial and enterprise SSD solutions. 

As generative AI and high-density computing evolve, thermal management is critical. To address this, SSSTC has optimized its SSDs for immersion cooling environments by enhancing corrosion resistance through specialized materials, component protection, and structural design. The lineup includes the SATA ER3, ER4, and ER5 series, as well as the PCIe® U.2 PJ1 and EJ5 series. 

These SSDs are optimized for immersion cooling environments, where systems are submerged in non-conductive dielectric fluids. By leveraging the high heat capacity and convective properties of liquids, heat can be efficiently dissipated through fluid circulation and heat exchange. This approach reduces reliance on traditional air cooling while improving Power Usage Effectiveness (PUE) and overall system reliability. 

SSSTC is also highlighting a range of industrial and enterprise SSDs optimized for AI and edge applications. Industrial SSDs support Edge AI and harsh environment deployments, with operating temperatures ranging from -40 °C to 85 °C, along with anti-vibration and shock-resistant designs for outdoor and industrial environments. The pSLC architecture enhances endurance for sustained write-intensive workloads, while a multi-tier PLP (Power Loss Protection) framework — including hardware PLP, firmware PLP, and PLN — provides flexible data protection. 

Enterprise eTLC SSDs are designed to deliver stable performance for AI workloads, offering endurance options of 1 and 3 DWPD over a five-year period for varying workload intensities. Under sustained workloads, they maintain more than 90% random IOPS consistency, minimizing performance fluctuations. Firmware optimized for high-density computing enables low latency operation, while capacitor-based PLP and immersion cooling support ensure reliable performance in demanding deployment environments. 

With more than 18 years of in-house firmware development expertise, SSSTC understands diverse storage requirements across industries and provides flexible customization options, including configurable over-provisioning, lifespan and capacity optimization, performance and power tuning, and application-specific firmware development. SSSTC remains committed to helping customers build stable, efficient, and sustainable AI storage infrastructures. 

About SSSTC 

Founded in 2008, SSSTC became a subsidiary of Kioxia Corporation in 2020 and delivers high-quality SSDs through in-house firmware and NAND expertise. For more information, visit the SSSTC website. 

Remark: PCIe is a registered trademark of PCI-SIG. 

Photo – https://mma.prnewswire.com/media/2992885/Computex_2026__SSD___AI___________SSSTC.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/computex-2026-ssstc-expands-immersion-cooling-ssd-portfolio-to-address-ai-data-center-thermal-challenges-302787916.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

Lexar showcases its full-stack AI storage capabilities and joint application scenarios with ASUS, spanning AI PCs, compact edge systems, and high-performance gaming platforms 

TAIPEI, June 2, 2026 /PRNewswire/ — Lexar today announced the latest evolution of its AI Storage Core vision at COMPUTEX 2026, showcasing a new generation of AI-aware storage solutions designed to support the growing demand for local AI workloads, AI PCs, compact edge systems, and high-performance computing. 

As AI workloads increasingly move from the cloud to local devices, storage is becoming more than passive capacity. It is becoming a critical part of how AI systems load models, move data, reduce latency, and maintain sustained performance. Lexar’s AI Storage Core is designed to address this shift through a combination of advanced packaging, chip hardware, Intelligent Scheduling, and system-level optimization. 

Building on this vision, Lexar is showcasing its AI-grade storage technology direction, high-performance SSD solutions, and expanded ecosystem collaboration with ASUS at COMPUTEX 2026. 

AI technology Solution: Advancing AI-Grade Gen5 Controller and Intelligent Scheduling Technologies 

At the core of AI Storage Core is Lexar’s integrated hardware-software solution around Longsys’ self-developed Gen5 controller SPU (Storage Processing Unit) and Intelligent Scheduling technologies. 

Built on an advanced 5nm process with a DRAM-less architecture, the SPU is designed to improve supply stability while maintaining high-performance AI storage capabilities in today’s constrained DRAM environment. 

Lexar’s Intelligent Scheduling engine is optimized for edge AI inference, addressing challenges such as large MoE models, huge parameter sizes, rapidly expanding KV Cache, and I/O latency impacting inference smoothness. Through intelligent workload scheduling, predictive prefetch algorithms, and optimized cache management, the platform significantly improves AI storage efficiency while reducing DRAM capacity requirements by approximately 40%. 

Together, chip hardware and Intelligent Scheduling allow storage to play a more active role in local AI performance, rather than simply serving as a place to store data. 

AI Product Portfolio: High-Performance Storage Solutions For AI Devices 

Building on its AI Storage Core capabilities, Lexar will showcase a range of high-performance storage solutions designed to support AI PCs, creator workflows, and compact edge devices. 

Lexar will showcase its next-generation AI-grade Gen5 SSD and AI-grade Gen5 Storage Stick concepts, designed to deliver bandwidth up to 11GB/s and provide a more flexible storage expansion path for compact AI devices. By combining high-bandwidth Gen5 performance with compact and adaptable form factors, these concepts aim to support future edge AI devices that require larger local model storage, faster model switching, lower-latency data access, and sustained performance within limited power and thermal environments. 

The NM1090 PRO 8TB PCIe Gen5 SSD is designed for AI PCs, creators, and users who need both large capacity and high bandwidth. Powered by PCIe Gen5 x4, it delivers read/write speeds up to 14,400 MB/s and 13,400 MB/s, with capacity up to 8TB, supporting large local AI models, high-resolution creative assets, and multiple AI applications running simultaneously on-device. 

Lexar will also display ARES RGB DDR5 128GB (64GBx2) 6400 C32 / 6000 C32, designed as a strong fit for AI PCs and high-performance systems. With large capacity and strong bandwidth, ARES RGB DDR5 helps support efficient local AI model deployment, generative AI workloads, creative production, gaming multitasking, delivering a more capable memory foundation for AI PC experiences. 

AI Ecosystem in Action: Lexar × ASUS for AI PCs 

At COMPUTEX 2026, Lexar and ASUS will showcase collaboration across three key scenarios: AI PC exploration, handheld gaming, and high-performance gaming memory. 

For AI PC exploration, Lexar will present an AI-grade Gen4 SSD model with the ASUS NUC 15 Pro Mini PC, demonstrating how AI-aware storage technologies may support compact AI PC environments. Lexar and ASUS are continuing technical discussions around future AI storage formats, including AI-grade Storage Stick concepts for more flexible expansion possibilities. 

Beyond AI PCs, Lexar and ASUS also showcased collaboration across gaming handhelds and PC gaming.For handheld gaming, Lexar will showcase PLAY X PCIe 4.0 M.2 NVMe SSD alongside the ROG XBOX ALLY, highlighting PLAY X’s compatibility and performance advantages for compact gaming systems. PLAY X supports both M.2 2230 and M.2 2280 configurations, delivers speeds up to 7,400 MB/s read and 6,500 MB/s write. It is now available through selected retail partners across Europe and APAC, including Amazon in Germany, France, and the UK, Tsukumo in Japan, Naver Smart Store in Korea, and PB Tech in New Zealand. 

Backed by more than 30 years of storage expertise and Longsys’ capabilities across controller design, firmware, advanced packaging, manufacturing, and validation, Lexar continues to expand beyond traditional storage products toward AI-aware storage solutions for the next generation of edge computing. 

Looking ahead, Lexar will continue expanding its AI Storage Core ecosystem with technology and platform partners. As edge AI use cases continue to mature, Lexar expects to work with more partners to explore commercial deployment opportunities across AI devices. 

Lexar welcomes media, partners, and industry visitors to explore its latest AI storage and high-performance memory solutions at COMPUTEX 2026 from June 2–5 at Booth No. R1006, Hall 2, 4F, Taipei Nangang Exhibition Center. 

Photo – https://mma.prnewswire.com/media/2991696/image1.jpgLogo – https://mma.prnewswire.com/media/2498763/5996138/Lexar_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/lexar-at-computex-2026-driving-next-generation-ai-pcs-and-edge-computing-with-ai-grade-storage-capabilities-302786941.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

SYDNEY, June 1, 2026 /PRNewswire/ — Flor de Caña, the sustainably crafted premium rum from Nicaragua, has been awarded the prestigious “Diamond Product Sustainability Award” by the organization Sustainability Award in Australia, the competition’s highest distinction and the first Diamond-level recognition granted in 2026. The award recognizes brands that demonstrate exceptional environmental performance and measurable sustainability impact throughout their value chain. 

The judges highlighted Flor de Caña’s industry-leading “field-to-bottle” sustainability model, which integrates renewable energy, carbon reduction initiatives, circular production practices, responsible packaging, and long-term environmental stewardship. As one of the world’s first Carbon Neutral spirits, Flor de Caña is distilled using 100% renewable energy, captures and repurposes all fermentation CO₂, and has planted more than one million trees since 2005. The award also recognized the brand’s premium quality, consistency, and craftsmanship developed over 135 years of family tradition. 

This recognition further strengthens Flor de Caña’s position as a global leader in sustainability within the spirits industry and reflects the company’s long-standing commitment to creating positive environmental and social impact. 

The brand has garnered international acclaim for its award-winning portfolio of premium rums aged naturally at the base of an active volcano in American white oak barrels without sugar or artificial ingredients. Notably, Flor de Caña’s 12 year-old, 18 year-old, and 25 year-old rums stand out for their distinctive flavor profiles and exceptionally smooth finish. 

The rum is distributed in Australia by Vanguard Luxury Brands. 

About Flor de CañaFlor de Caña is a premium rum brand that is Carbon Neutral certified and sustainably made, from field to bottle. From an 1890 family estate, it’s distilled with 100% renewable energy and naturally aged at the base of an active volcano without sugar or artificial ingredients. Recognized as a global leader in sustainability, the brand has received distinctions such as “World’s Most Sustainable Rum Brand” (USA), “Ethical Award” (UK) and “Sustainable Spirits Producer” (France). www.flordecana.com  

Media Contact: corporatecommunications@flordecana.com
 

Logo – https://mma.prnewswire.com/media/2992342/Flor_de_Can_a_12_and_18_Year.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/flor-de-cana-receives-highest-sustainability-recognition-in-australia-302787605.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

Approval Based Upon Phase 3 DeLLphi-304 Trial Demonstrating 40% Reduction in Risk of Death with IMDYLLTRA Compared to Chemotherapy  

Novel Treatment Option for Patients with Extensive-Stage Small Cell Lung Cancer That Has Progressed   

THOUSAND OAKS, Calif., June 1, 2026 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has granted marketing authorization for IMDYLLTRA® (tarlatamab) as a monotherapy to treat adults with extensive-stage small cell lung cancer (ES-SCLC) who require systemic therapy following disease progression on or after first-line treatment with platinum-based chemotherapy. 

The approval was based on results from DeLLphi-304, the first global Phase 3 trial to demonstrate a significant survival benefit over chemotherapy in this setting.1
 

“Small cell lung cancer is one of the most aggressive solid tumors, with high rates of relapse following first-line treatment and limited treatment options,” said Jean-Charles Soria, senior vice president of Oncology at Amgen. “The European Commission’s approval of IMDYLLTRA, the first and only T-cell engager therapy approved to treat small cell lung cancer, marks an important step forward for patients in Europe and reflects our commitment to advancing innovative medicines that can meaningfully improve outcomes for people living with this devastating disease.” 

DeLLphi-304, the global Phase 3 clinical trial, demonstrated that IMDYLLTRA reduced the risk of death by 40% and significantly extended median overall survival (OS) by more than five months compared to standard of care (SOC) chemotherapy as a treatment for patients with ES-SCLC who progressed on or after one line of platinum-based chemotherapy (median OS: 13.6 vs. 8.3 months; hazard ratio (HR), 0.60; 95% confidence interval (CI): 0.47, 0.77; P < 0.001).1   

“Patients with small cell lung cancer have historically faced a hard road when they progress after initial treatment, surviving only a few months,” said Debra Montague, president, Lung Cancer Europe (LuCE). “Approval of a novel treatment option for people in Europe living with this challenging cancer represents meaningful progress and underscores the urgent need for innovation in lung cancer care.” 

The safety profile for IMDYLLTRA was consistent with its known profile. The most common adverse reactions were cytokine release syndrome (CRS) (56.7%), decreased appetite (36.4%), pyrexia (31.9%), dysgeusia (31.3%), constipation (30.4%), anaemia (30.0%), fatigue (29.8%), nausea (24.9%), asthenia (19.0%), neutropenia (16.9%), hyponatraemia (16.7%), headache (16.3%) and lymphopenia (15.6%). The most common serious adverse reactions were CRS (19.7%) and pyrexia (4.7%). 

CRS primarily occurred after the first two doses. As reflected in the Summary of Product Characteristics (SmPC), patients should be monitored from the start of the IMDYLLTRA infusion for 6 to 8 hours on Cycle 1 Day 1 and Cycle 1 Day 8 in an appropriate healthcare setting.2
 

Amgen’s robust IMDYLLTRA clinical development program includes the DeLLphi clinical trials, which evaluate IMDYLLTRA as a monotherapy and as part of combination regimens, including in both earlier stages of SCLC and earlier lines of treatment.   

About the Phase 3 DeLLphi-304 StudyDeLLphi-304 is a global Phase 3, randomized, controlled, open-label clinical trial evaluating the efficacy and safety of IMDYLLTRA as a treatment for patients living with SCLC who progressed on or after one platinum-based chemotherapy regimen. Five hundred and nine patients were randomized to receive either IMDYLLTRA or local standard of care chemotherapy (topotecan in all countries except Japan; lurbinectedin in the U.S., Canada, Australia, Singapore, South Korea; and amrubicin in Japan). The primary outcome measure of the trial is OS. Key secondary outcome measures include progression-free survival (PFS) and patient-reported outcomes (PROs) including disease-related symptoms, physical function, and quality of life.3 Results from DeLLphi-304 were reviewed as a late-breaking presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The New England Journal of Medicine.1,4
 

About IMDELLTRA®/IMDYLLTRA® (tarlatamab)IMDYLLTRA is a first-in-class targeted immunotherapy engineered by Amgen researchers to bind to both DLL3 on tumor cells and CD3 on T cells, thereby activating T cells to kill DLL3-expressing SCLC cells. This results in the formation of a cytolytic synapse with lysis of the cancer cell. 5,6 DLL3 is a protein that is expressed on the surface of SCLC cells in up to 96% of patients with SCLC, but is minimally expressed on healthy cells, making it an exciting target.7,8  

About Small Cell Lung Cancer (SCLC)   SCLC is one of the most aggressive and devastating forms of solid tumor cancer. Each year, SCLC accounts for approximately 13-15% of more than 2.4 million cases of lung cancer diagnosed worldwide.9-11 Despite initial high response rates to first-line platinum-based chemotherapy, most patients quickly relapse within months and require subsequent treatment options.10    

About Tarlatamab Clinical TrialsTarlatamab is being investigated in multiple studies including DeLLphi-303, a Phase 1b study investigating tarlatamab in combination with SOC therapies in first-line ES-SCLC; DeLLphi-305, a randomized Phase 3 study comparing tarlatamab in combination with durvalumab vs. durvalumab alone in first-line ES-SCLC in the maintenance setting; DeLLphi-306, a randomized placebo-controlled Phase 3 study of tarlatamab following concurrent chemoradiotherapy in limited-stage SCLC; DeLLphi-308, a Phase 1b study evaluating subcutaneous tarlatamab in second-line or later ES-SCLC; DeLLphi-309, a Phase 2 study evaluating alternative intravenous dosing regimens with tarlatamab in second-line ES-SCLC; DeLLphi-310, a Phase 1b study of tarlatamab in combination with YL201, a B7-H3 targeting antibody drug conjugate, with or without anti-programmed death ligand 1 (PD-L1) in patients with ES-SCLC; DeLLphi-311, a Phase 1b study of tarlatamab in combination with etakafusp alfa (AB248), a novel CD8+ T-cell selective interleukin-2 (IL-2), in patients with ES-SCLC; DeLLphi-312, a randomized Phase 3 study evaluating tarlatamab in combination with carboplatin, etoposide and durvalumab as an induction and maintenance therapy in first-line treatment of ES-SCLC; and DeLLphi-313, a Phase 1b study of tarlatamab in combination with zocilurtatug pelitecan, a DLL3 targeting antibody drug conjugate, with and without a PD-L1 inhibitor in patients with ES-SCLC.12
 

For more information, please visit www.tarlatamabclinicaltrials.com. 

About AmgenAmgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines. 

More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions. 

Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. 

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads. 

EU INDICATION 

IMDYLLTRA® (tarlatamab) is indicated as monotherapy for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC), who require systemic therapy following disease progression on or after first-line treatment with platinum-based chemotherapy. 

IMPORTANT SAFETY INFORMATION  

WARNINGS AND PRECAUTIONS  

ADVERSE REACTIONS   

DOSAGE AND ADMINISTRATION: Important Dosing Information   

U.S. INDICATION  

IMDELLTRA® (tarlatamab-dlle) is indicated for the treatment of adult patients with extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy in the United States. 

IMPORTANT SAFETY INFORMATION  

WARNING: CYTOKINE RELEASE SYNDROME and NEUROLOGIC TOXICITY including IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 

WARNINGS AND PRECAUTIONS  

ADVERSE REACTIONS   

DOSAGE AND ADMINISTRATION: Important Dosing Information   

Please see U.S. IMDELLTRA® full Prescribing Information, including BOXED WARNINGS.  

Amgen Forward-Looking StatementsThis news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeOne Medicines Ltd.), the performance of Otezla® (apremilast), our acquisitions of ChemoCentryx, Inc., Dark Blue Therapeutics, Ltd. or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon’s business, performance and opportunities, and any potential strategic benefits, synergies or opportunities expected as a result of such acquisition), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.  

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. Even when clinical trials are successful, regulatory authorities may question the sufficiency for approval of the trial endpoints we have selected. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market.  

Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions, including those resulting from geopolitical relations and government actions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico, and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful, and may result in unanticipated costs, delays or failures to realize the benefits of the transactions. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our sustainability objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. 

CONTACT: Amgen, Thousand Oaks Annik Allen, 917-288-9136 (media)Elissa Snook, 609-251-1407 (media)Casey Capparelli, 805-447-1746 (investors)  

REFERENCES 

Logo – https://mma.prnewswire.com/media/213782/5994848/AMGEN_LOGO_V2.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/european-commission-approves-amgens-imdylltra-for-the-treatment-of-extensive-stage-small-cell-lung-cancer-302787410.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

MONTECATINI TERME – Domenico Giani è stato riconfermato alla presidenza della Confederazione nazionale delle Misericordie d’Italia. La decisione è arrivata dall’assemblea elettiva nazionale riunita a Montecatini Terme, che ha rinnovato la fiducia all’attuale vertice dell’organizzazione di volontariato più antica d’Italia.

La notizia ha raccolto subito le congratulazioni del presidente della Regione Toscana, Eugenio Giani, che ha espresso il proprio apprezzamento a nome dell’intera giunta regionale. “Questa riconferma – ha dichiarato – è il giusto riconoscimento per l’eccellente lavoro svolto in questi anni con dedizione, lealtà e profondo spirito di servizio”.

Il presidente della Regione ha anche ricordato il ruolo centrale che le Misericordie ricoprono nel tessuto sociale del paese: organizzazioni nate in Toscana quasi otto secoli fa e oggi punto di riferimento per migliaia di persone in difficoltà su tutto il territorio nazionale.

“Le Misericordie rappresentano un pilastro fondamentale del nostro sistema sociale e di volontariato – ha aggiunto Eugenio Giani – un orgoglio nato in Toscana che da quasi otto secoli offre un aiuto concreto e solidale a chi soffre”.

Con la riconferma di Domenico Giani alla guida delle Misericordie d’Italia, la Confederazione prosegue nel solco di un percorso già avviato, con l’obiettivo di rafforzare ulteriormente la rete di assistenza e volontariato che caratterizza da secoli questa storica istituzione.

REDAZIONE

PRESS RELEASE 

Bloomberg (THEON:NA) / Reuters (THEON.AS) 

1 June 2026 – Theon International Plc (THEON)  announces new orders totaling €42 million in Q2 2026 to date, with an additional €27 million in associated options. The majority relates to Kappa Optronics’ (KAPPA) Vehicle Awareness Systems for several hundred armored vehicles in a European Union country, with deliveries spanning from 2026 to 2028. The order will be funded through the EU’s SAFE (Security Action For Europe) mechanism, allowing other countries to join under the same contract, creating potential for additional new business and growing orders. Together with the recently announced PHYLAX order, it supports THEON’s expansion into the platform-based segment and its broader revenue growth and diversification strategy. 

Year-to-date, total order intake and new options stand at €144 million and €67 million respectively, reflecting sustained momentum across NVGs and the newer products. As stated earlier in the year, THEON targets to maintain an elevated book-to-bill ratio of above 1.0x in FY 2026. The majority of order intake is typically realized in H2, with a particularly strong concentration in Q4, reflecting the seasonality of the business. Ongoing geopolitical developments and Europe’s commitment to rearmament continue to underpin demand for defense equipment and THEON’s broadened product offering. THEON has full confidence in its current FY 2026 guidance which represents revenue increase of c. 30% on FY 2025, of which more than 20% is expected to be organic. 

Philippe Mennicken, Deputy CEO and Business Development Director of THEON, stated: “This KAPPA order represents more than 50% of its current annual revenues and was secured just over four months after the deal closed. KAPPA’s product portfolio was combined with THEON’s commercial reach to secure a meaningful addition to our backlog. It’s a testament and great illustration of the top-line commercial synergies we can achieve through our recently acquired companies, leveraging our strong BD network and customers’ trust. We expect to further accelerate our push into platforms through our investment in MERIO, and other targeted initiatives and business opportunities”. 

For inquiries, please contact: 

About THEON GROUP 

THEON GROUP of companies develops and manufactures cutting-edge night vision and thermal imaging systems for Defense and Security applications with a global footprint. THEON GROUP started its operations in 1997 from Greece and today occupies a leading role in the sector thanks to its international presence through subsidiaries and production facilities in Greece, Cyprus, Germany, the Baltics, the United States, the Gulf States, Switzerland, Denmark, Belgium, Singapore and South Korea. THEON GROUP has more than 280,000 systems in service with Armed and Special Forces in 72 countries around the world, 26 of which are NATO countries. ΤΗΕΟΝ ΙΝΤΕRNATIONAL PLC has been listed on Euronext Amsterdam (AMS: THEON) since February 2024.www.theon.com
 

Attachment
 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/globenewswire

YEREVAN, Armenia, June 1, 2026 /PRNewswire/ — Armen Pogossian, Owner of Pogossian Luxury Brand House, became the first Armenian entrepreneur to appear within the Forbes Under 30 platform in China, marking a significant milestone for Armenian entrepreneurship, luxury craftsmanship, and international business representation. 

Pogossian was invited to participate in the 2024–2025 Forbes 30 Under 30 Summit China, held at Zhengzhou Sias University in Henan Province alongside the 2026 Forbes China Economic Forum. His presence at the prestigious gathering highlighted not only his growing international profile, but also Armenia’s expanding voice in global entrepreneurship, luxury branding, and cross-border collaboration. 

Held under the forward-looking theme “Jumpstarting the Future,” the two-day summit brought together an influential community of past and present Forbes China Under 30 honorees, global financial and business leaders, visionary investors, industry judges, academic pioneers, and senior Forbes China executives. 

The summit opened with an exclusive welcome reception in the French Garden of Zhengzhou Sias University, where remarks were delivered by Herman Chik, Head of International Business at Forbes China, and Niu Xiaoyu, Party Secretary of Zhengzhou Sias University. The setting created a powerful atmosphere for dialogue, innovation, and connection among the next generation of leaders. 

As part of the summit’s high-level dialogue, Armen Pogossian shared his perspective on the role of young entrepreneurs in shaping the future of global business. 

“Future entrepreneurs do not simply follow trends; they create them in an ever-changing market. Bringing together individuals who share this vision of excellence makes transformative change inevitable. My experience at the Forbes Under 30 Summit proved that by exchanging ideas, embracing innovation, and remaining open to borderless collaboration, we can begin to see and shape a part of the future before it even arrives.” 

Throughout the summit, Pogossian engaged with leading entrepreneurs, innovators, investors, and business figures from across China and beyond. His participation reflected a broader mission: to connect Armenian excellence with international platforms that recognize talent, ambition, and future-focused leadership. 

The summit’s main program featured five keynote speeches and three specialized roundtable forums, covering topics including AI-powered smart hardware, domestic computing power ecosystems, new consumer brand logic, and embodied intelligent robotics. 

A major highlight of the event was the highly anticipated Under 30 Awards Gala, where honorees from the 2024 and 2025 Forbes China Under 30 lists were celebrated. The evening spotlighted the diversity, ambition, and vision driving China’s newest generation of business leaders. 

During the summit, the elegantly designed Jardins d’Arménie booth attracted notable attention from guests, offering an immersive tasting experience that introduced attendees to the distinctive character and heritage of the royal brandy. The activation further strengthened Armenia’s cultural and luxury presence within the Forbes Under 30 environment. 

Pogossian Luxury Brand House supported the successful execution of the summit alongside a prestigious group of corporate partners, including iSoftStone, Plug and Play China, Dreame AI Smart Ring, and MarcumAsia. 

Armen Pogossian is the 27 year old owner of Pogossian Luxury Brand House, one of the fastest growing international luxury groups built on a family legacy of craftsmanship, creativity, and excellence. Representing a new generation of Armenian entrepreneurs, Pogossian continues to expand the presence of innovative luxury across global markets. 

Since the early 1990s, the Pogossian family has been creating exceptional luxury products rooted in craftsmanship and refinement. Based in Armenia and present in more than 40 countries, Pogossian Luxury Brand House embodies a vision of creativity, excellence, and immersive brand experiences designed for an international clientele. 

Photo – https://mma.prnewswire.com/media/2992278/Pogossian_1.jpgPhoto – https://mma.prnewswire.com/media/2992279/Pogossian_2.jpgPhoto – https://mma.prnewswire.com/media/2992280/Pogossian_3.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/armen-pogossian-represents-armenia-at-forbes-under-30-summit-china-empowering-the-next-generation-of-global-entrepreneurs-302787357.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire